Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 69, Issue 4, 2001, Pages 318-327

  Rea, Thomas H ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; DAPSONE; HEMOGLOBIN; INTERLEUKIN 6; MINOCYCLINE; PREDNISONE; RIFAMPICIN; SERUM ALBUMIN; THALIDOMIDE;

ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHEMA NODOSUM LEPROSUM; ERYTHROPOIESIS; HEMODILUTION; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; LEPROMATOUS LEPROSY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ANEMIA; DAPSONE; ERYTHEMA NODOSUM; HEMOGLOBINS; HUMANS; LEPROSTATIC AGENTS; LEPROSY, LEPROMATOUS; PREDNISONE; RETROSPECTIVE STUDIES; SERUM ALBUMIN; THALIDOMIDE;

EID: 0035738612     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Interleukin-6-associated anemia: Determination of the underlying mechanism
2. Serum iron and total iron binding capacity in leprosy patients
3. Biocomplexity: Look at the whole, not the parts
4. Effect of dapsone on haemoglobin concentration in patients with leprosy
5. Anemia of chronic disease in rheumatoid arthritis: In vivo effects of tumor necrosis factor alpha blockade
6. Regulation of iron metabolism in the acute-phase response: Interferon [gamma] and tumor necrosis factor [alpha] induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients
7. Increased vascular permeability: A major cause of hypoalbuminaemia in disease and injury
8. Correlation between TNF production, increased C-reactive protein level and suppression of T-lymphocyte response to concanavalin A during erythema nodosum leprosum
9. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes
10. Electrophoretic pattern of serum proteins in leprosy
11. Thalidomide in the treatment of erythema nodosum leprosum
12. Clinical and histologic discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP
13. IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans
14. Electrophoretic pattern of serum proteins in leprosy
15. IL-6 production in response to purified mycobacterial heat-shock proteins and to antigen 85 in leprosy
16. Serum albumin: Touchstone or totem?
17. Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leukocytosis in leprosy
18. The anemia of chronic disorders
19. Cytokine mRNA expression in leprosy: A possible role for interferon-[gamma] and interleukin-12 in reactions (RR and ENL)
20. Recombinant human interleukin-6 induces a rapid and reversible anemia
21. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
22. Lepromatous and tuberculoid leprosy: Clinical presentation and cytokine responses
23. Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biological effects
24. Induction of transcription factor AP-2 by inflammatory cytokines in human keratinocytes
25. Serum tumor necrosis factor and interleukin 1 in leprosy and during leprosy reactions
26. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions
27. Delayed-typed hypersensitivity reactions followed by erythema nodosum leprosum
28. Histological classification and the immunological spectrum of leprosy
29. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum leprosum
30. Pentoxifylline decreases in vivo and in vitro tumor necrosis factor-alpha (TNF-[alpha]) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL)
31. Serum levels of tumor necrosis factor-alpha and interleukin-1 beta during leprosy reactional states
32. Patterns of erythropoiesis and anemia in leprosy
33. Serum iron and total iron binding capacity in Burmese patients with leprosy
34. Concurrent phase I trials of intravenous interleukin-6 in solid tumor patients: Reversible dose-limiting neurological toxicity
35. Effects of recombinant tumor necrosis factor (rTNFα) in cancer. Observations on the acute phase protein reaction and immunoglobulin synthesis after high dose recombinant TNF-alpha administration in isolated limb perfusions in cancer patients
36. Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach
37. Cytokine patterns of immunologically mediated tissue damage